https://www.aafp.org/afp/2006/0601/p2018
Rimonabant Is Minimally Effective for Weight Loss | AFP
for weight lossrimonabanteffectiveafp
https://blogs.bmj.com/heart/2010/10/14/rimonabant-fails-to-reach-a-crescendo-2/
Rimonabant fails to reach a CRESCENDO - Heart
Nov 12, 2015 - Rimonabant is a selective cannabinoid-1 receptor antagonist that has previously been shown to reduce waist circumference and body weight, in addition to...
rimonabantfailsreachcrescendoheart
https://pubmed.ncbi.nlm.nih.gov/23103902/
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and...
The acute effects of cannabinoid compounds have been investigated in animal models of anxiety-like behavior and palatability processing. However, the chronic...
https://markets.businessinsider.com/news/stocks/mira-reports-mira-55-shows-no-thc--rimonabant-associated-cns-side-effects-1035955831
Mira reports Mira-55 shows no THC-, Rimonabant-associated CNS side effects | Markets Insider
MIRA Pharmaceuticals (MIRA) announced new preclinical data demonstrating that Mira-55 did not produce cannabinoid-like central nervous system si...
https://pmc.ncbi.nlm.nih.gov/articles/PMC3136184/
Rimonabant: From RIO to Ban - PMC
Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century....
from riorimonabantpmc
https://pubmed.ncbi.nlm.nih.gov/22716153/
Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human...
Several lines of experimental and clinical evidence point to a close relationship between cannabis, the endogenous cannabinoid system, and schizophrenia. A...
systematic reviewantipsychoticlikeeffectscannabidiol